Cancer Researchers
-
{
- All
- News
- Videos
-
Survived A Brain Tumour? Here's How Cell Therapy Could Support Recovery
Cell therapy, often referred to as a form of regenerative medicine, uses living cells or cell-derived products to support the body's natural repair mechanisms.
-
Unexpected Immune System Mechanism Found To Attack Cancer, Scientists Reveal
Many modern cancer treatments, including immunotherapy, depend on activating killer T cells to recognise and destroy tumours.
-
Smart Cancer Drug Can Shrink Tumours By 30% In Early Trial
In an early-stage (Phase 1) trial of 83 patients, the drug shrank tumours in 26 people. For 15 of those patients, their tumours shrank by at least 30%.
-
Is There A Safe Alcohol Consumption Limit? Major Review Reveals When Health Risks Rise
A major new review has reignited debate over whether any amount of alcohol is safe. Researchers found health risks begin rising even at low levels of drinking, challenging long-held beliefs about "moderate" alcohol consumption and its supposed benefits.
-
Major Breakthroughs In Pancreatic Cancer Treatment And Weight Loss Medication Benefits Discussed At ASCO Summit
Cancer researchers highlighted several treatment breakthroughs during their annual summit in Chicago that concluded Tuesday, including preliminary but encouraging data on potential...
-
New Drug-Vaccine Combo Cuts Melanoma Recurrence Risk By Nearly 50%, Finds Study
Researchers have found that a combination of a personalised cancer vaccine and an immunotherapy drug can significantly lower the chances of the disease returning after surgery. This treatment has shown benefits, even after five years of follow-up.
-
Cancer Most Dangerous In Middle Age, Not Old Age Due To Immune System Vulnerability: Study
Scientists have long observed that although cancer risk rises with age, rates appear to decline somewhat among people over 80 or 85 years old.
-
Pancreatic Cancer Breakthrough: New Daily Pill Doubles Survival Time For Advanced Patients
A new once-daily targeted therapy, daraxonrasib, has nearly doubled survival in patients with advanced pancreatic cancer in a landmark Phase 3 trial. Experts are calling it one of the most significant breakthroughs against one of the world's deadliest cancers in decades.
-
Largest Shortages In Cancer Workforce In 2050 Could Be Nurses, Diagnostic Specialists: Study
Scaling up the global cancer workforce could reduce mortality by over 50 percent in 55 countries, notably in Africa, Central America, and South Asia.
-
Experimental Pill Promises New Hope For Deadly Pancreatic Cancer
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.
-
India Faces Severe Stem Cell Donor Crisis For Blood Cancer Patients, Say Experts
Thousands of blood cancer patients in India struggle to access life-saving stem cell transplants due to severe donor shortages, delayed diagnosis and low awareness. Experts warn that expanding India's donor registry is urgently needed to improve survival chances
-
Lancet Study Flags Mental Disorders As Top Cause Of Global Disability
The world's burden of mental disorders has more than doubled since 1990, and they are now the leading cause of disability globally, overtaking cardiovascular disease, cancer and musculoskeletal conditions, according to a new study published in The La
-
HIV Study: Boosting Immune Cells May Help Fight Infection
Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells.
-
New Swab Test Could Detect Tuberculosis In Under 1 Hour
Researchers have developed a fast, non-invasive tongue swab test for tuberculosis that could transform global TB diagnosis. The portable test delivers accurate results in under an hour and may improve detection in hard-to-test patients.
-
Nutritional Support To 2.8 Million Tuberculosis Patients Could Avert 120,000 Deaths Yearly: Study
Researchers in collaboration with India's National Tuberculosis Elimination Programme (NTEP) found that food support is a cost-effective way to improve health outcomes for people with TB in 94 per cent of the study's simulations.
-
Survived A Brain Tumour? Here's How Cell Therapy Could Support Recovery
Cell therapy, often referred to as a form of regenerative medicine, uses living cells or cell-derived products to support the body's natural repair mechanisms.
-
Unexpected Immune System Mechanism Found To Attack Cancer, Scientists Reveal
Many modern cancer treatments, including immunotherapy, depend on activating killer T cells to recognise and destroy tumours.
-
Smart Cancer Drug Can Shrink Tumours By 30% In Early Trial
In an early-stage (Phase 1) trial of 83 patients, the drug shrank tumours in 26 people. For 15 of those patients, their tumours shrank by at least 30%.
-
Is There A Safe Alcohol Consumption Limit? Major Review Reveals When Health Risks Rise
A major new review has reignited debate over whether any amount of alcohol is safe. Researchers found health risks begin rising even at low levels of drinking, challenging long-held beliefs about "moderate" alcohol consumption and its supposed benefits.
-
Major Breakthroughs In Pancreatic Cancer Treatment And Weight Loss Medication Benefits Discussed At ASCO Summit
Cancer researchers highlighted several treatment breakthroughs during their annual summit in Chicago that concluded Tuesday, including preliminary but encouraging data on potential...
-
New Drug-Vaccine Combo Cuts Melanoma Recurrence Risk By Nearly 50%, Finds Study
Researchers have found that a combination of a personalised cancer vaccine and an immunotherapy drug can significantly lower the chances of the disease returning after surgery. This treatment has shown benefits, even after five years of follow-up.
-
Cancer Most Dangerous In Middle Age, Not Old Age Due To Immune System Vulnerability: Study
Scientists have long observed that although cancer risk rises with age, rates appear to decline somewhat among people over 80 or 85 years old.
-
Pancreatic Cancer Breakthrough: New Daily Pill Doubles Survival Time For Advanced Patients
A new once-daily targeted therapy, daraxonrasib, has nearly doubled survival in patients with advanced pancreatic cancer in a landmark Phase 3 trial. Experts are calling it one of the most significant breakthroughs against one of the world's deadliest cancers in decades.
-
Largest Shortages In Cancer Workforce In 2050 Could Be Nurses, Diagnostic Specialists: Study
Scaling up the global cancer workforce could reduce mortality by over 50 percent in 55 countries, notably in Africa, Central America, and South Asia.
-
Experimental Pill Promises New Hope For Deadly Pancreatic Cancer
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.
-
India Faces Severe Stem Cell Donor Crisis For Blood Cancer Patients, Say Experts
Thousands of blood cancer patients in India struggle to access life-saving stem cell transplants due to severe donor shortages, delayed diagnosis and low awareness. Experts warn that expanding India's donor registry is urgently needed to improve survival chances
-
Lancet Study Flags Mental Disorders As Top Cause Of Global Disability
The world's burden of mental disorders has more than doubled since 1990, and they are now the leading cause of disability globally, overtaking cardiovascular disease, cancer and musculoskeletal conditions, according to a new study published in The La
-
HIV Study: Boosting Immune Cells May Help Fight Infection
Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells.
-
New Swab Test Could Detect Tuberculosis In Under 1 Hour
Researchers have developed a fast, non-invasive tongue swab test for tuberculosis that could transform global TB diagnosis. The portable test delivers accurate results in under an hour and may improve detection in hard-to-test patients.
-
Nutritional Support To 2.8 Million Tuberculosis Patients Could Avert 120,000 Deaths Yearly: Study
Researchers in collaboration with India's National Tuberculosis Elimination Programme (NTEP) found that food support is a cost-effective way to improve health outcomes for people with TB in 94 per cent of the study's simulations.
